SYS-CON MEDIA Authors: Jim Kaskade, Yeshim Deniz, Elizabeth White, Greg Ness, Sean Houghton

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

 

DUBLIN, Mar. 20, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/sq2qm5/injectable_drug) has announced the addition of the "Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)" conference to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London

KEY TOPICS TO INCLUDE:
- Market trends
- Human factors and useability
- Fluid dynamics - modelling the realities of injection performance
- Delivery of high viscosity drugs
- Case study presentation on devices in development
- Latest self injection trends
- Development of a parenteral device
- Delivery of high volumes
- Compliance modelling and parenteral drug delivery
- The insulet drug delivery system

DATES:

26 & 27 March 2014

TIMES:

Day One: 26 March 2013
Start times: 9.30 Finish 17.45

Drinks Reception Followed by Dinner 19.30

Day Two: 27 March 2013
Start times: 9.00 Finish 16.15

VENUE FOR CONFERENCE AND DINNER:

Le Meridien Hotel, Piccadilly, London

NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.

Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged

Key Topics Covered:

INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013

09.30 - Chairman's Welcome and Introduction
Dr Gregory Berman,
Head of Innovation and Technology Management Group, Sagentia, UK

09.40 - Key Note Address: Market Trends

- High concentration formulations

- Larger doses, less frequent injections
Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA

10.20 - Human Factors and Useability

- Ethonographic research on atuoinjector use for chronic conditions

- Relationship between a disease and its therapy - emotional and functional levels

- How this affects device selection
Mathew Young, CEO, Oval Medical Technologies Ltd, UK

11.00 - Discussion followed by Coffee

11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance

- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early

- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device

- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later

- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken

- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user

- Early understanding of device issues supports and enables robust designs and capable manufacture

- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible
Andy Fry, Founder, Team Consulting, UK

12.10 - Delivery of High Viscosity Drugs

- Device formats

- Overcoming the challenges
Speaker, (invited)

12.50 - Discussion followed by Lunch

14.10 - Mixing Technologies for Reconstitution Devices

- Market Needs - Industry drivers and demands for these types of devices

- Latest mixing technologies

- Comparison of Lyophilised and Spray drying technologies

- Technical challenges with these types of devices
Tom Bailey, Managing Director, 3PInnovation, UK

14.50 - Device Case Study
Ian Anderson, Innovation Director, Bespak UK (invited)

15.30 - Discussion followed by Tea

16.10 - Latest Self Injection Trends

- General market trends

- Trends for biologics

- Trends for generics

- Pre-configured devices

- Future outlook
Mats Persson, Managing Director, SHL Group, Sweden

16.50 - Innovation in Primary Container Materials

- Trends for user requirements intended for self injection

- Material technology options and selection criteria

- Integration of Quality by Design for components

- Platform approach for lifecycle management
Tibor Hlobik, West Pharmaceutical Services

17.30 - Discussion

17.45 - End of Day One

19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London

INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013

09.00 - Review of Day One
Dr Gregory Berman,
Head of Innovation and Technology Management Group, Sagentia, UK

09.10 - What Does Pharma Want From its Drug Delivery Suppliers
Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK

09.50 - Pump Technology Case Study
Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)

10.30 - Discussion followed by Coffee

11.10 - Compliance Monitoring and Parenteral Drug Delivery

- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)

- Advances in wireless communications enabling intelligent compliance monitoring

- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education

- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient

- Regulatory issues associated with connected health systems and smartphone apps

- Using the cloud to store and disseminate data securely
Mark Tuckwell, Senior Consultant, Connected Health Systems,
Sagentia, UK

11.50 - Wireless Communication and Electronics for Compliance Monitoring

- Patient therapy compliance continues to be one of the biggest challenges in health systems

- 50% of all patients do not complete required treatment

- Reasons for the high rate of non-compliance

- Opportunities for medical manufacturers to offer innovative solutions

- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers

- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance
Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel

12.30 - Discussion followed by Lunch

14.00 - Update on Regulations and Standards
Lee Leichter, President P/L Medical, USA

14.40 - The Insulet Drug Delivery System

Consists of two components
- Drug Delivery Pod
- Drug Delivery Manager

A Programmable, body worn, disposable, subcutaneous infusion pump

- Delivers up to 2ml of drug product over a three day period
- Delivery rate from 0.5 to 300 µl/hr
- Automated catheter insertion
- Waterproof (IPX8 25 feet for up to 60 minutes)

Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems
Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA

15.20 - The Rise of the Bolus Injector

The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:

- The changing needs of patients and new drugs

- Could autoinjectors and infusion pumps meet the needs?

- Bolus injectors: a new class of injection device

- Example devices

- What to expect from the draft standard ISO 11608-6' on bolus injectors.
Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK

16.00 - Discussion and Chairman's Closing Remarks

16.15 - End of Conference and Tea


For more information visit http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact: Laura Wood , +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today Isomorphic Software, the global leader in high-end, web-based business applications, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Isomorphic Software is the global leader in high-end, web-based business applications. We develop, market, and support the SmartClient & Smart GWT HTML5/Ajax platform, combining the productivity and performance of traditional desktop software ...
The security devil is always in the details of the attack: the ones you've endured, the ones you prepare yourself to fend off, and the ones that, you fear, will catch you completely unaware and defenseless. The Internet of Things (IoT) is nothing if not an endless proliferation of details. It's the vision of a world in which continuous Internet connectivity and addressability is embedded into a growing range of human artifacts, into the natural world, and even into our smartphones, appliances, a...
Fundamentally, SDN is still mostly about network plumbing. While plumbing may be useful to tinker with, what you can do with your plumbing is far more intriguing. A rigid interpretation of SDN confines it to Layers 2 and 3, and that's reasonable. But SDN opens opportunities for novel constructions in Layers 4 to 7 that solve real operational problems in data centers. "Data center," in fact, might become anachronistic - data is everywhere, constantly on the move, seemingly always overflowing. Net...
SYS-CON Events announced today that Gridstore™, the leader in hyper-converged infrastructure purpose-built to optimize Microsoft workloads, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Gridstore™ is the leader in hyper-converged infrastructure purpose-built for Microsoft workloads and designed to accelerate applications in virtualized environments. Gridstore’s hyper-converged infrastructure is the ...
"ElasticBox is an enterprise company that makes it very easy for developers and IT ops to collaborate to develop, build and deploy applications on any cloud - private, public or hybrid," stated Monish Sharma, VP of Customer Success at ElasticBox, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"Matrix is an ambitious open standard and implementation that's set up to break down the fragmentation problems that exist in IP messaging and VoIP communication," explained John Woolf, Technical Evangelist at Matrix, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges. In his session at @ThingsExpo, Jeff Kaplan, Managing Director of THINKstrateg...
The Internet of Things promises to transform businesses (and lives), but navigating the business and technical path to success can be difficult to understand. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, demonstrated how to approach creating broadly successful connected customer solutions using real world business transformation studies including New England BioLabs and more.
How do APIs and IoT relate? The answer is not as simple as merely adding an API on top of a dumb device, but rather about understanding the architectural patterns for implementing an IoT fabric. There are typically two or three trends: Exposing the device to a management framework Exposing that management framework to a business centric logic Exposing that business layer and data to end users. This last trend is the IoT stack, which involves a new shift in the separation of what stuff happe...
An entirely new security model is needed for the Internet of Things, or is it? Can we save some old and tested controls for this new and different environment? In his session at @ThingsExpo, New York's at the Javits Center, Davi Ottenheimer, EMC Senior Director of Trust, reviewed hands-on lessons with IoT devices and reveal a new risk balance you might not expect. Davi Ottenheimer, EMC Senior Director of Trust, has more than nineteen years' experience managing global security operations and asse...
DevOps is all about agility. However, you don't want to be on a high-speed bus to nowhere. The right DevOps approach controls velocity with a tight feedback loop that not only consists of operational data but also incorporates business context. With a business context in the decision making, the right business priorities are incorporated, which results in a higher value creation. In his session at DevOps Summit, Todd Rader, Solutions Architect at AppDynamics, discussed key monitoring techniques...
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at @ThingsExpo, Robin Raymond, Chief Architect...
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to th...
What do a firewall and a fortress have in common? They are no longer strong enough to protect the valuables housed inside. Like the walls of an old fortress, the cracks in the firewall are allowing the bad guys to slip in - unannounced and unnoticed. By the time these thieves get in, the damage is already done and the network is already compromised. Intellectual property is easily slipped out the back door leaving no trace of forced entry. If we want to reign in on these cybercriminals, it's hig...
The definition of IoT is not new, in fact it’s been around for over a decade. What has changed is the public's awareness that the technology we use on a daily basis has caught up on the vision of an always on, always connected world. If you look into the details of what comprises the IoT, you’ll see that it includes everything from cloud computing, Big Data analytics, “Things,” Web communication, applications, network, storage, etc. It is essentially including everything connected online from ha...